Federal Register / Vol. 71, No. 173 / Thursday, September 7, 2006 / Notices 52807 

Contact Person: Robert J. Wenthold, PhD, 

Director, Division of Intramural Research, 

National Institute on Deafness and Other 

Communication Disorders, 5 Research Court, 

Room 2B28, Rockville, MD 20852. 301–402–

2829. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.173, Biological Research 

Related to Deafness and Communicative 

Disorders, National Institutes of Health, HHS) 

Dated: August 29, 2006. 

Anna Snouffer, 

Acting Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 06–7469 Filed 9–6–06; 8:45am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Diabetes and 

Digestive and Kidney Diseases; Notice 

of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The contract proposals and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the contract 

proposals, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Diabetes and Digestive and Kidney Diseases 

Special Emphasis Panel, RFP NIH–NIDDK–

06–05, Liver Tissue and Cell Distribution 

System (LTCDS). 

Date: September 18, 2006. 

Time: 2 p.m. to 3:30 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: National Institutes of Health, Two 

Democracy Plaza, 6707 Democracy 

Boulevard, Bethesda, MD 20892 (Telephone 

Conference Call). 

Contact Person: Paul A. Rushing, PhD, 

Scientific Review Administrator, Review 

Branch, DEA, NIDDK, National Institutes of 

Health, Room 747, 6707 Democracy 

Boulevard, Bethesda, MD 20892–5452. (301) 

594–8895. rushingp@extra.niddk.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.847, Diabetes, 

Endocrinology and Metabolic Research; 

93.848, Digestive Diseases and Nutrition 

Research; 93.849, Kidney Diseases, Urology 

and Hematology Research, National Institutes 

of Health, HHS) 

Dated: August 29, 2006. 

Anna Snouffer, 

Acting Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 06–7471 Filed 9–6–06; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Diabetes and 

Digestive and Kidney Diseases; Notice 

of Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The contract proposals and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the contract 

proposals, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Diabetes and Digestive and Kidney Diseases 

Special Emphasis Panel, USRDS 

Coordinating Center proposal review. 

Date: September 25, 2006. 

Time: 8:30 a.m. to 10 a.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: Bethesda Marriott Suites, 6711 

Democracy Boulevard, Bethesda, MD 20817. 

Contact Person: Lakshmanan Sankaran, 

PhD, Scientific Review Administrator, 

Review Branch, DEA, NIDDK, National 

Institutes of Health, Room 755, 6707 

Democracy Boulevard, Bethesda, MD 20892–

5452, (301) 594–7799, Is38oz@nih.gov. 

Name of Committee: National Institute of 

Diabetes and Digestive and Kidney Diseases 

Special Emphasis Panel, USRDS Special 

Studies Centers Contract Proposals Review. 

Date: September 25, 2006. 

Time: 10 a.m. to 1:30 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: Bethesda Marriott Suites, 6711 

Democracy Boulevard, Bethesda, MD 20817. 

Contact Person: Lakshmanan Sankaran, 

PhD, Scientific Review Administrator, 

Review Branch, DEA, NIDDK, National 

Institutes of Health, Room 755, 6707 

Democracy Boulevard, Bethesda, MD 20892–

5452, (301) 594–7799, Is38oz@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.847, Diabetes, 

Endocrinology and Metabolic Research; 

93.848, Digestive Diseases and Nutrition 

Research; 93.849, Kidney Diseases, Urology 

and Hematology Research, National Institutes 

of Health, HHS) 

Dated: August 29, 2006. 

Anna Snouffer, 

Acting Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 06–7472 Filed 9–6–06; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Library of Medicine; Notice of 

Meeting 

Notice is hereby given of the second 

meeting of the Working Group on 

Chemical Information Resource 

Coordination under the National Library 

of Medicine’s (NLM) Board of Scientific 

Counselors, National Center for 

Biotechnology Information (NCBI). 

The meeting will be open to the 

public, with attendance limited to space 

available. Individuals who plan to 

attend and need special assistance, such 

as sign language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

The mission of the Working Group on 

Chemical Information Resource 

Coordination is to advise the Board of 

Scientific Counselors, NCBI, on 

interactions with private sector 

information providers in the 

development of the PubChem database. 

PubChem is a publicly available 

database that includes information 

about the biological activities of 

chemical compounds, and is designed 

to facilitate more integrated access to 

these information resources for 

biomedical researchers. The working 

group will: (1) Establish a process for 

retrospective evaluation of the 

biomedical relevance of compounds 

entered into PubChem, (2) Ensure the 

provenance of the data (i.e., whether 

private data are being improperly 

deposited into PubChem), (3) Ensuring 

the high quality of data in PubChem, (4) 

Monitoring the effect of PubChem on 

scientific progress, (5) Improving/ 

Integrating interactions with 

commercial information providers, and 

(6) Avoiding unnecessary duplication 

with commercial information providers. 

This working group supports part of the 

National Institutes of Health’s Roadmap, 

called the Molecular Libraries Initiative. 

Name of Committee: Working Group on 

Chemical Information Resource 

Coordination. 

Date: October 16, 2006. 

Time: 10 a.m. to 3 p.m. 


rwilkins on PROD1PC63 with NOTICES
52808 Federal Register / Vol. 71, No. 173 / Thursday, September 7, 2006 / Notices 

Agenda: Discussion on the NLM/NCBI 

PubChem Database. 

Place: National Library of Medicine, 

Building 38, Board Room, 2nd Floor, 8600 

Rockville Pike, Bethesda, MD 20894. 

Contact Person: David J. Lipman, M.D., 

Director, National Center for Biotechnology 

Information, National Library of Medicine, 

NIH, Building 38A, Room 8N803, Bethesda, 

MD 20894, 301–496–2475. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The comments should include 

the name, address, telephone number and, 

when applicable, the business or professional 

affiliation of the interested person. 

Dated: August 30, 2006. 

Anna Snouffer, 

Acting Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 06–7466 Filed 9–6–06; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Library of Medicine; Notice of 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of a meeting of the 

Board of Scientific Counselors, National 

Center for Biotechnology Information. 

The meeting will be open to the 

public as indicated below, with 

attendance limited to space available. 

Individuals who plan to attend and 

need special assistance, such as sign 

language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

The meeting will be closed to the 

public as indicated below in accordance 

with the provisions set forth in section 

552b(c)(6), Title 5 U.S.C., as amended 

for the review, discussion, and 

evaluation of individuals conducted by 

the National Library of Medicine, 

including consideration of personnel 

qualifications and performance, and the 

competence of individual investigators, 

the disclosure of which would 

constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Board of Scientific 

Counselors, National Center for 

Biotechnology Information. 

Date: October 17, 2006. 

Open: 8:30 a.m. to 12 p.m. 

Agenda: Program Discussion. 

Place: National Library of Medicine, 

Building 38, Board Room, 2nd Floor, 8600 

Rockville Pike, Bethesda, MD 20892. 

Closed: 12 p.m. to 2 p.m. 

Agenda: To review and evaluate personal 

qualifications and performance, and 

competence of individual investigators. 

Place: National Library of Medicine, 

Building 38, Board Room, 2nd Floor, 8600 

Rockville Pike, Bethesda, MD 20892. 

Open: 2 p.m. to 5 p.m. 

Agenda: Program Discussion. 

Place: National Library of Medicine, 

Building 38, Board Room, 2nd Floor, 8600 

Rockville Pike, Bethesda, MD 20892. 

Contact Person: David J. Lipman, MD, 

Director, Natl Ctr for Biotechnology 

Information, National Library of Medicine, 

Department of Health and Human Services, 

Building 38A, Rom 8N805, Bethesda, MD 

20894, 301–435–5985, 

dlipman@mail.nih.gov. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

In the interest of security, NIH has 

instituted stringent procedures for entrance 

onto the NIH campus. All visitor vehicles, 

including taxicabs, hotel, and airport shuttles 

will be inspected before being allowed on 

campus. Visitors will be asked to show one 

form of identification (for example, a 

government-issued photo Id, driver’s license, 

or passport) and to state the purpose of their 

visit. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.879, Medical Library 

Assistance, National Institutes of Health, 

HHS) 

Dated: August 30, 2006. 

Anna Snouffer, 

Acting Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 06–7467 Filed 9–6–06; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Library of Medicine; Notice of 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of a meeting of the 

PubMed Central National Advisory 

Committee. 

The meeting will be open to the 

public, with attendance limited to space 

available. Individuals who plan to 

attend and need special assistance, such 

as sign language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

Name of Committee: PubMed Central 

National Advisory Committee, 

Date: October 26, 2006. 

Time: 9:30 a.m. to 4 p.m. 

Agenda: Review and Analysis of Systems. 

Place: National Library of Medicine, 

Building 38, 2nd Floor, Board Room, 8600 

Rockville Pike, Bethesda, MD 20892. 

Contact Person: David J. Lipman, MD, 

Director, Natl Ctr for Biotechnology 

Information, National Library of Medicine, 

Building 38, Room 8N805, Bethesda, MD 

20894. 301–435–5985. 

dlipman@mail.nih.gov. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

In the interest of security, NIH has 

instituted stringent procedures for entrance 

onto the NIH campus. All visitor vehicles, 

including taxicabs, hotel, and airport shuttles 

will be inspected before being allowed on 

campus. Visitors will be asked to show one 

form of identification (for example, a 

government-issued photo ID, driver’s license, 

or passport) and to state the purpose of their 

visit. 

Information is also available on the 

Institute’s/Center’s home page: http:// 

www.pubmedcentral.nih.gov/about/nac.html, 

where an agenda and any additional 

information for the meeting will be posted 

when available. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93,879, Medical Library 

Assistance, National Institutes of Health, 

HHS) 

Dated: August 30, 2006. 

Anna Snouffer, 

Acting Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 06–7468 Filed 9–6–06; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Office of the Director, National 

Institutes of Health; Amended Notice 

of Meeting 

Notice is hereby given of a change in 

the meeting of the Recombinant DNA 

Advisory Committee, September 20, 

2006, 1 p.m. to 5 p.m., National 

Institutes of Health, Natcher Building, 

45 Center Drive, Conference Room D, 

Bethesda, MD 20892 which was 

published in the Federal Register on 

August 18, 2006, 71 FR 160 page 47821. 

The meeting will be held from 12 p.m. 

to 6 p.m. instead of 1 p.m. to 5 p.m. The 

meeting is open to the public. 

Dated: August 30, 2006. 

Anna Snouffer, 

Acting Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 06–7464 Filed 9–6–06; 8:45 am] 

BILLING CODE 4140–01–M 


rwilkins on PROD1PC63 with NOTICES